Tomomi Fujisawa
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017.
Journal: Breast cancer (Tokyo, Japan)
Published: May 29, 2026
Primary tumour resection reduces the risk of major local morbidity in de novo stage IV breast cancer: secondary data analysis from the JCOG1017 randomized controlled trial.
Journal: The British journal of surgery
Published: March 21, 2026
De-escalation of perioperative systemic therapy for early breast cancer.
Journal: Japanese journal of clinical oncology
Published: March 21, 2026
De-escalation of breast surgery for early stage breast cancer.
Journal: Japanese journal of clinical oncology
Published: March 14, 2026
Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trial.
Journal: Breast cancer (Tokyo, Japan)
Published: January 27, 2026
Clinical complete response and predictive factors in HER2-positive early breast cancer treated with neoadjuvant chemotherapy aimed at omission of surgery: an exploratory analysis of the JCOG1806 trial.
Journal: International journal of clinical oncology
Published: November 25, 2025
Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial.
Journal: Breast (Edinburgh, Scotland)
Published: November 19, 2025
Radiofrequency Ablation for Early Stage Breast Cancer as a Potential Alternative to Partial Mastectomy: 5-Year Results from the Multiple-Center, Single-Arm, Phase 3 RAFAELO Study (NCCH1409).
Journal: Annals of surgical oncology
Published: October 28, 2025
Efficacy and prognostic predictors of primary systemic therapy for de novo Stage IV breast cancer. Exploratory analysis of JCOG1017 PRIM-BC.
Journal: Breast cancer (Tokyo, Japan)
Published: October 04, 2025
Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017.
Journal: Breast cancer (Tokyo, Japan)
Published: August 29, 2025
Erratum: Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 11, 2025
Pertuzumab Retreatment for Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced/Metastatic Breast Cancer (PRECIOUS Study): Final Overall Survival Analysis.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 24, 2025
Last Updated: 09/26/2026